Invitrogen™ Endoglin (CD105) Human ELISA Kit

Ref.: BL-RE-091776Manufacturer ref.: EHENG 96 tests
€730.00 excl. VAT

Kit ELISA Endoglin sandwich (human): quantitative determination of Hu Endoglin in serum, plasma, a buffered solution or cell culture medium. The test recognizes only the natural and recombinant forms of Hu endoglin.

Accession number
P17813
Dose range
12.35-3000 pg/ml
Sensitivity of the dosage
10 pg/ml
Calibration range
10 pg/ml to 3000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen

Kit ELISA Endoglin sandwich (human): quantitative determination of Hu Endoglin in serum, plasma, a buffered solution or cell culture medium. The test recognizes only the natural and recombinant forms of Hu endoglin.

Kit ELISA Endoglin sandwich (human): quantitative determination of Hu Endoglin in serum, plasma, a buffered solution or cell culture medium. The test recognizes only the natural and recombinant forms of Hu endoglin.

Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.

Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).

CD105 (endoglin is a Type I transmembrane protein) is strongly expressed in human vascular endothelial cells and is present on an O- and N-glycosylated homodimer. Positive CD105 expression regulation was shown in tumour vasculature and proliferation cells, suggesting that it is a marker of proliferation-associated endothelial cells. CD105 is strongly expressed on endothelial cells and promotes l-angiogenesis during wound healing, infarction and in a wide range of tumours, its genetic expression is stimulated by hypoxia. The CD105 binds to TGF beta 1 and 3 with a high affinity but not to TGF beta 2. Mutations of the CD105 gene cause hereditary haemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, a dominant autosomal multisystemic vascular dysplasia. Spiculated transcription variants encoding different CD105 isoforms were also found. Diseases associated with CD105 dysfunction include inherited haemorrhagic telangiectasia.

Sensitivity

Sensitivity of dosage: 10 pg/ml.

Measurement range

Dose range: 12.35-3000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Intradose variation coefficient < 10%, interdose < 12%.

Target

Target: Human.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15404983
Specifications
Accession numberP17813
Dose range12.35-3000 pg/ml
Sensitivity of the dosage10 pg/ml
Calibration range10 pg/ml to 3000 pg/ml
DoseELISA solid-phase sandwich
ConjugateBiotin
Product typeKit ELISA
Protein familyArterial morphogenesis; BMP signaling pathway; bone development; cell adhesion; cell chemotaxia; cell migration; cell migration involved in the formation of an endocardic cushion; cell motility; cellular response to mechanical stimuli; vasculogous
Type of sampleSerum, Surnatant, Surnatant
SpecificityThis ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, ENA-78, FGF- 4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma,
Sufficient for96 dosages
Target speciesHuman
For use with (application)ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)2022
Gene symbol(s)END,HHT1,ORW1
Coefficient of inter-dose variation< 12 %
Coefficient of intra-dose variation< 10 %
Contents of kits96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers
Marker or dyeHRP
Quantity96 tests
Regulatory statusRUO
Research disciplinesExtracellular Matrix & Cell Adhesion
SynonymRP11-228B15.2, END, HHT1, ORW 1
TargetHuman
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 5 μl; serum, 5 μl; supernatant, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EHENG
Country of originUnited States
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.